Investigating a training supporting shared decision making (IT'S SDM 2011): study protocol for a randomized controlled trial by Geiger, Friedemann et al.
STUDY PROTOCOL Open Access
Investigating a training supporting shared
decision making (IT’S SDM 2011): study protocol
for a randomized controlled trial
Friedemann Geiger
1,2*, Katrin Liethmann
3, Frauke Hoffmann
4, Jutta Paschedag
2 and Jürgen Kasper
5,6
Background: Shared Decision Making (SDM) is regarded as the best practice model for the communicative
challenge of decision making about treatment or diagnostic options. However, randomized controlled trials
focusing the effectiveness of SDM trainings are rare and existing measures of SDM are increasingly challenged by
the latest research findings. This study will 1) evaluate a new physicians’ communication training regarding patient
involvement in terms of SDM, 2) validate SDMMASS, a new compound measure of SDM, and 3) evaluate the effects
of SDM on the perceived quality of the decision process and on the elaboration of the decision.
Methods: In a multi-center randomized controlled trial with a waiting control group, 40 physicians from 7 medical
fields are enrolled. Each physician contributes a sequence of four medical consultations including a diagnostic or
treatment decision.
The intervention consists of two condensed video-based individual coaching sessions (15min.) supported by a
manual and a DVD. The interventions alternate with three measurement points plus follow up (6 months).
Realized patient involvement is measured using the coefficient SDMMASS drawn from the Multifocal Approach to
the Sharing in SDM (MAPPIN’SDM) which includes objective involvement, involvement as perceived by the patient,
and the doctor-patient concordance regarding their judges of the involvement. For validation purposes, all three
components of SDMMASS are supplemented by similar measures, the OPTION observer scale, the Shared Decision
Making Questionnaire (SDM-Q) and the dyadic application of the Decisional Conflict Scale (DCS). Training effects
are analyzed using t-tests. Spearman correlation coefficients are used to determine convergent validities, the
influence of involvement (SDMMASS) on the perceived decision quality (DCS) and on the elaboration of the
decision. The latter is operationalised by the ELAB coefficient from the UP24 (Uncertainty Profile, 24 items version).
Discussion: Due to the rigorous blinded randomized controlled design, the current trial promises valid and reliable
results. On the one hand, we expect this condensed time-saving training to be adopted in clinical routine more likely
than previous trainings. On the other hand, the exhaustivity of the MAPPIN’SDM measurement system qualifies it as a
reference measure for simpler instruments and to deepen understanding of decision-making processes.
Trial registration: Current Controlled Trials ISRCTN78716079
Background
Medical decision making and the important role of
communication
Good clinical practice is characterized by valuable inter-
actions between an informed and activated patient and a
proficient, proactive health care team [1]. Such
interactions require a patient-health provider communi-
cation that is patient-centered, and responsive to patient
needs, values, and preferences [2]. Effective communica-
tion has been associated with improvement in medical
and psychological outcomes, greater patient confidence
in and adherence to treatment plans, increased care
satisfaction, and improved trust in health care providers
[3]. Moreover, thorough patient information is an ethi-
cal obligation for the care provider [2,4]. For decisions
about diagnostic or treatment options, a shared
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patients exchange information and perspectives is
increasingly regarded as the ideal model [5]. SDM is
characterized by a discussion of different options and
outcomes and by the fact that patient and physician
arrive at a consensus. To have unbiased and under-
standable information about options evidence-based
patient information has been considered a prerequisite
of SDM [6].
SDM is particularly suited to medical situations meet-
ing the equipoise condition - when none of the available
options appears clearly superior for an individual patient
[7]. The equipoise condition is especially relevant to
decisions regarding chronic illnesses with uncertain
prognoses and for which treatments are only partially
effective, or associated with important side-effects.
One of the most cited goals of SDM is to support
medical decisions that are informed and coherent with
patients’ values [8]. However, the mediating principle by
which SDM is hypothesized to achieve this goal has not
yet been described. The method itself remains insuffi-
ciently operationalized [9,10].
Measuring involvement
There are few instruments designed to measure SDM in
clinical practice. One of the instruments most frequently
used is the Observing Patient Involvement (OPTION)
scale, in which an independent observer measures the
extent to which clinicians initiate behavior to involve
patients during the consultation [11]. This measurement
strategy isn’t sufficient to study clinical decision-making in
its dyadic and relationship-centered approach. It is crucial
to assess simultaneously patient and clinician behavior,
and looking at the interaction by analysis of the fitting of
communicative styles between a given patient and his phy-
sician [10,12,13]. It has been shown judging medical com-
munication from different perspectives (physicians,
patients and external observers) leads to discrepant results
[14-17], and none of the existing measurement approaches
can be regarded as a gold standard to assess the degree of
sharing in the decision-making dyad [12,18,19]. Although
the OPTION scale has provided valuable data about deci-
sion-making processes, it is only able to represent external
assessments; the perceptions of participants involved in
the consultation remain unavailable [20]. Based on reviews
of SDM assessment instruments [12,19] a new tool, the
“Multifocal approach to the sharing in SDM” (MAPPIN’
SDM) has recently been developed in Hamburg (see below
for details).
The role of uncertainty in processing a medical decision
and methodological implications
The decision-making process in the clinical encounter is
influenced by its inherent uncertainty and by the reaction
of physicians and patients to this uncertainty. Uncer-
tainty is a feature of many aspects of physician-patient
risk communication. Uncertainty is inherent in the indi-
vidual prognosis and in the capacity of a treatment to
improve the patient’s health. Uncertainty is inherent in
assessment of the physician’s competence as well as in
the assessment of the patient’s understanding of given
explanations. Uncertainty is also inherent in the interpre-
tation of statistics, especially when evidence is lacking.
Most of the uncertainties cannot be resolved within a
conversation but nevertheless have to be managed.
Abstracting from the particular decision, for instance on
a prostate cancer screening or treatment for relapses of
multiple sclerosis, we define uncertainty as the core con-
tent of the decisional communication. Uncertainty is
referred to in some of the SDM literature [7,21,22]. For
instance, reducing awareness of uncertainty is seen as an
important goal of risk communication by some authors
[23]. Given the context of uncertainty, decisional conflict
is one of the key elements in decision making in clinical
settings [24]. “Decisional conflict is defined as an indivi-
dual perception of uncertainty about which course of
action to take when choice among competing options
involves risk, loss, regret, or challenge to personal life
values. In lay terms, decisional conflict refers to the level
of comfort that an individual experiences when facing a
difficult decision. Decisional conflict should not be con-
fused with the uncertainty inherent in the nature of the
available scientific evidence. Until recently, decisional
conflict in patients as well as in physicians had been stu-
died at the level of the individual rather than at the level
of the dyad, thus ignoring the interpersonal system that
is at play. Individuals involved in dyadic interactions,
even brief ones, can, and often do, influence each other’s
cognitions, emotions, and behaviours” [25]. Beyond this
more quantitative approach to perception of uncertainty
the methodological concept of SDM has to specify a
strategy to communicate uncertainty [26]. Such a strategy
might mean support for a patient, since awareness of var-
ious uncertain aspects in a decision prevents the patient
from achieving a position of clarity. Negotiation of uncer-
tainties in the medical encounter should lead to changes
in the patient’s cognitive representation of uncertain
aspects. Beyond increasing or reducing uncertainty in the
perception of the person concerned, such negotiation can
change the state of the cognitive representation. There is
a need for a theory about people’s perception of decisio-
nal uncertainty and about the way it changes when they
elaborate information relevant for this decision [27].
Objectives
1. To evaluate a new intervention’s ability to
enhance physicians’ communication behavior and to
improve the communication in terms of SDM.
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e x p r e s s i n gt h ed e g r e et o which a communication
involved physician and patient in an evidence-based
decision making process as the gold standard for
measuring SDM.
3. To evaluate SDM regarding its effects on patients’
decisional conflict and internal processes of
elaboration.
Sub goals
- To further validate the short version of the Uncer-
tainty Profile questionnaire (UP24) which is supposed to
assess an individual’s perception of uncertain aspects
when facing a decision.
- To yield data on the interrelatedness of different
perspectives on communication.
The project builds up on own previous studies and is
structured to address all three study questions within
one clinical trial.
Methods
Trial Design
This is a multi-center randomized controlled trial com-
paring a group of physicians which receives training
with a waiting control group regarding the SDM perfor-
mance of the doctor-patient-dyad. Within the total pool
of consultations, in both groups the impact of the actual
communication level according to SDM on indicators of
thorough elaboration of the decision will be investigated
(see Figure 1).
Participants
As the study sample medical consultations between phy-
sicians and patients will be monitored in seven univer-
sity outpatient clinics in Germany (oncology,
gynecology, psychiatry, neurology, dentistry, radiology).
Consultations are eligible if the physician expects a
medical decision to be negotiated within the encounter.
Patients are included in the study only one time, while
physicians document a sequence of four consultations
each.
Intervention
The intervention is a training curriculum (doktor-
mitSDM [28]) addressing the doctors and goaling
(intending) at stimulating efforts to involve their
patients in the decision making process. It has been
developed based on the newest available scientific
knowledge on evidence-based patient information
(EBPI) and SDM [29,30]. Its didactic is inspired by
training techniques from psychotherapy education and
enables the participants to incorporate the theoretical
framework of reference in their cognitive system by use
of examples drawn from own communication behavior.
Therefore, the training both coaches the physicians as
observers of communication and provides feedback to
them.
In particular, the training includes 3 educational
components:
i1. The manual: It was developed to comprehensively
explain background and idea of SDM as well as a set of
15 SDM skills which represent an extension of the
range of skills published by Elwyn et al. [11,31]. Within
the manual examples are used to illustrate varying
degrees of performance.
i2. The training video: Corresponding with the manual
a training video was developed and produced. It demon-
strates excellent performance of each of the 15 indica-
tors applied to a decision on immunotherapy in
multiple sclerosis. The video shows a neurologist talking
to a patient. The consultation is role play based on a
prepared script. Within the video, each skill is verbally
edited according to the MAPPIN’SDM framework.
i3. The face to face feedback: Trainees get structured
feedback based on an assessment of a video-recorded
own consultation in terms of the same framework of
reference. The feedback session lasts a maximum of 15
minutes and follows a guideline passing 6 separate steps:
1. intro via surveying subjective benefit of the pre-
vious training steps
2. statement that feedback does not refer to commu-
nication performance in general, but just to our spe-
cific viewpoint. The trainer indicates, that there are
a lot of other important aspects of communication,
one could focus on. The present focus is the way the
physician involves the patient into the decision to be
made.
3. actualization of the specific consultation. Report-
ing context or particular events. e.g. by presenting a
sequence of the video. Noting subject of the decision
and duration of the decision sequence
4. concrete positive feedback referring to observable
skills supported by presentation of video sequences.
5. investigation of the doctor’s ideas regarding
potential for improvement
6. suggestions regarding potential improvement.
Concrete examples are provided which as far as pos-
sible build up on existing competencies. Checking
understanding. Reassuring tolerable volume of input.
The training deliberately abandons to provide the trai-
nees with a general judgment of their performance, or
to reach completeness in the feedback of the communi-
cation skills. Furthermore, the feedback is not intended
to go beyond the concrete consultation for instance by
relating it to other consultations. The feedback aims at
concreteness and traceability.
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As it is considered important that the trial does not
negatively affect the practice process by burdening phy-
sicians and patients too much, measurement is limited
to the necessary amount of instruments. Most of the
measures were tested in previous studies to explore item
properties and validity. In particular measures were
selected to assess:
Figure 1 Flow of randomly assigned participants in the two experimental conditions.
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making process using the MAPPIN’SDM inventory
(objective judgment based on video-tapes, physician
and patient questionnaires (15 items each))
b. the patients’ perception of SDM using the SDM-Q
(9 items)
c. to which extent involvement (in terms of SDM)
impacts on the dyadic perception of decisional con-
flict using the Decisional Conflict scale (16 items to
be administered by physicians and patients)
d. patients’ cognitive representation of decision
related uncertainty using the UP24 (24 items to be
administered by the patient before and after the
consultation).
Measuring involvement by use of the MAPPIN’SDM
approach
MAPPIN’SDM [32] is a measurement system compris-
ing 7 coherent views on SDM: I) SDM related behavior
shown by 1) patient, 2) doctor, 3) the doctor-patient-
dyad, judged by an independent observer on the basis of
video documents; II) the doctor’sp e r c e p t i o no f4 )t h e
dyad’s SDM related behavior and 5) its perceived result;
III) the patient’s perception of 6) the dyad’s SDM related
behavior and 7) its perceived result. Each focus is
assessed by the identical set of 15 criteria with slightly
adapted formulations. This set incorporates all items of
the OPTION scale [11,31] plus 4 indicators considered
essential in the SDM literature.
While the complete system with 7 foci was initially
developed to consequently map every possible view on
SDM and thereby their interrelatedness [32], SDM can
be sufficiently defined by a combination of 3 noteworthy
parts. We call a decision making process “shared” if a)
SDM behavior is shown by the doctor-patient-dyad
(focus 3), b) the patient gets the impression of being
involved (focus 7), and c) doctor and patient share this
impression (concordance between foci 7 and 5). The
formula below shows how the 3 parts are adjusted and
combined to a compound measure called SDMMASS
(SDMmeeting its concept’s assumptions). SDMMASS
ranges from 0 to 1, where 0 indicates no SDM and 1
indicates perfect SDM.
SDMMASS =
M(MAPPIN − Qpatient)
4
+
M(MAPPIN − Odyad)
4
+ τ1−15(MAPPIN − Qpatient; MAPPIN − Qdoctor)
3
MAPPIN - Qpatient: Patient questionnaire addressing
his/her perceived result of SDM
MAPPIN - Odyad: Observer rating addressing the
realized amount of SDM on the dyadic level
MAPPIN - Qdoctor: Physician questionnaire addres-
sing his/her perceived result of SDM
M: Mean of items of the particular domain (range 0-
4)
τ1-15:K e n d a l l ’s tau coefficient indicating consensus
(concordance) on items 1-15; negative values are
fixed at 0.
SDMMASS serves as primary endpoint for the evaluation
of the training (study question 1). Accordingly, in the
present study each consultation is measured using the
three observer foci (MAPPIN-Odoctor , MAPPIN-Opatient ,
MAPPIN-Odyad) based on video data. Observation based
analyses (3 × 15 items = 45 items per consultation) will
be conducted by two independently working trained
MAPPIN’SDM raters with previously proven inter-rater-
agreement. Doctors and patients each judge the per-
ceived SDM result by use of the MAPPIN-Qpatient /MAP-
PIN-Qdoctor after the consultation. Before filling in the
questionnaires both parties shall cooperatively define the
specific medical decision they will refer to. Completing
these questionnaires requires about 5 minutes.
In addition, OPTION scores will be extracted from
the observer data. OPTION serves as secondary end-
point of study question 1 and is used to validate MAP-
PIN-Odyad (study question 2).
Measuring involvement of the patient using the Shared
Decision Making Questionnaire (SDM-Q)
The Shared Decision Making Questionnaire [33]
assesses patients’ view of a consultation. The question-
naire follows the same taxonomy of decision making as
the OPTION scale and was developed to show the
extent to which patients feel they were involved in the
process. In its revised form SDM-Q has 9 items scoring
from 0 to 3 on a 4 point Likert scale [34]. Filling in the
SDM-Q requires about 5 minutes.
In the present trial, the SDM-Q will be used to vali-
date the first component (MAPPIN-Qpatient)o f
SDMMASS (study question 2).
In order to limit the overall number of items, SDM-Q
will be assessed only in those centers where the UP24 is
not applicable (see below).
Measuring effects of involvement using the Decisional
conflict scale (DCS)
Decisional conflict defined as above can be measured by
the Decisional Conflict Scale [21,35]. The DCS is a mul-
tidimensional scale of 16 items divided into 5 subscales:
personal uncertainty (3 items) and its modifiable deficits
of feeling uninformed (3 items), unclear values (3
items), inadequate support (3 items), and perception
that an ineffective choice has been made (4 items).
Meanwhile the DCS exists as a dyadic measure [36].
This application form of the DCS provides analogue
items for patients and physicians. Completing the DCS
requires about 5 minutes.
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(DCSdoctor,D C S patient) of the doctor-patient-dyad pro-
vides the opportunity to focus two kinds of parameters:
1) the mean decisional conflict on total and single scale
level viewed by the physician and by the patient and 2)
the concordance of DCS ratings indicating the extent to
which elaboration of the decision took place on an
interpersonal level (in terms of SDM). The latter focus,
operationalized by the median of Kendall’s tau coeffi-
cient for the five subscales, will be used for the valida-
tion of the concordance parameter in SDMMASS (study
question 2). The absolute DCSpatient score in relation to
the actual level of SDM serves as primary endpoint for
the evaluation of SDM effects (study question 3).
DCSdoctor and DCSpatient are assessed after each
consultation.
Measuring effects of involvement using the Uncertainty
Profile questionnaire (UP24)
The Uncertainty Profile questionnaire (formerly known
as QUiCC) measures the way decision related uncer-
tainty is represented within the patient’sc o g n i t i v es y s -
tem and displays the intensity and profile of the
patient’s perception [37,38]. It assesses decisional uncer-
tainty in eight distinct empirically grounded categories.
Corresponding to the original Uncertainty Profile
questionnaire with 41 items, a short version (UP24) was
developed. Each category is represented by three items.
The UP24 shows good psychometric quality regarding
validity, internal consitency and retest reliability. Filling
in the UP24 requires about 10 minutes [39].
The UP24 can be analysed on two levels: 1) a measure
of the level of uncertainty that is perceived and 2) a
measure of elaboration of a decision that is indicated by
the degree of differentiation between qualities of uncer-
tainty. The latter is addressed by study question 3. For
assessment of elaboration of the decision, a special coef-
ficient (called ELAB) was invented (see formula below).
Differentiation itself is operationalized by inter-scale var-
iance. To eliminate biases caused by varying global
levels of uncertainty due to individual cognitive and
coping styles, each scale value is adjusted by each
patient’s individual grand mean over all eight uncer-
tainty scales. Subtracting 1 from these adjusted mean
scale values leads to positive values for scales above the
average and negative values for those below without
affecting the inter-scale variance [38]. In the present
study, UP24 is administered before and after each con-
sultation. The increase of elaboration (ΔELAB: differ-
ence between both measurement points) in relation to
the actual level of SDM serves as secondary endpoint of
study question 3.
The use of UP24 will be limited to consultations with
ill patients (in contrast to people considering e.g. a
screening). The UP24 is not used in the entire study
population hence.
ELAB = Var

M1
Mtotal
− 1

,

M2
Mtotal
− 1

···

M8
Mtotal
− 1

Var: Variance
M1-8: Mean scale values of the eight uncertainty
scales
Mtotal:E a c hp e r s o n ’s individual grand mean of
uncertainty scales
Recording of additional information
To yield sufficient description of the study sample, diag-
nosis, sex and age of the patients will be recorded by
the physician. Furthermore, profession, years of practical
experience, age and sex of the physician will be regis-
tered. Both physician and patient have to name the deci-
sion (or its deferment) that has been made in the
consultation.
Randomization and Blinding
Randomization will be conducted by an independent
person administering randomization lists (block rando-
mization within each study center). Investigators
involved in enrollment of physicians into the trial have
no access to the randomization list. Concealment of
allocation towards the participating physicians is consid-
ered. Physicians are informed about being randomized
to one of two study arms, within which components of
the intervention are provided in different order. It is
emphasized, however, that both groups receive the same
training modules. Observation based judgments of the
dyad’s SDM performance are done by two indepen-
dently working raters in random order. The video docu-
ments to be judged do not include information about
study arm affiliation or training stage. Thus these ratings
are blinded.
Statistical Methods
Success of randomization is checked using baseline
scores of the primary endpoint SDMMASS, age and sex
as well as practice experience of the physicians. Training
effects in terms of differences between baseline and post
intervention assessment are analyzed using Student’st -
test. This procedure takes possible baseline imbalances
regarding SDMMASS into account. However, if signifi-
cant imbalances occurred, their influence on validity had
to be discussed. Spearman correlation coefficients are
used to determine convergent validities, the influence of
involvement (SDMMASS) on the perceived decision qual-
ity (DCS) and on the increase of elaboration of the
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ficient from the UP24 (Uncertainty Profile, 24 items ver-
sion). Possible cluster effects within the study centers or
physicians which may mask correlations or produce arti-
ficial ones will be detected by analyzing grouped scatter
plots.
Sample Size
The calculation of the required sample size is primarily
oriented towards the demands of study question 1
which addresses the evaluation of the training.
We aim at a power of 85%. Given an effect size of d =
.9 (which was already realized with a former version of
the training), a one-tailed t-test for two independent
samples with an alpha of .05, a total sample size of N =
36 is needed. In order to take possible drop-outs into
account, the sample size is expanded to N = 40.
Regarding study question 2 (validation of the compo-
nents of SDMMASS), a number of N = 36 physicians
(minimum after possible drop-outs) leads to 4 × 36 =
144 consultations in the whole study. Given alpha = .05,
power = .85, this sample size would require correlations
of .22 between the components of SDMMASS and the
external criteria OPTION and DCSconcordance.F o rt h e
validation of the patient component by use of SDM-Q,
only N = 76 consultations are available since the
remaining complete the UP24 instead. This demands a
correlation of at least .30 to yield significant results.
Both these values are far below our expectations.
Regarding study question 3, correlation between
SDMMASS and DCSpatient has to exceed .22 (N = 144).
Correlation between SDMMASS and ΔELAB has to go
beyond .31 (N = 68). Both is regarded as achievable.
Summing up, determining sample size according to
study question 1 leads to sufficient power regarding the
remaining study questions.
Discussion
This trial introduces a rigorous double-blinded rando-
mized controlled study design. All measures and the
intervention itself are either widely validated interna-
tionally and/or thoroughly tested in preliminary stu-
dies of our group. Compared to other trainings that
have proven effective for training physicians in SDM,
the doktormitSDM intervention is highly condensed,
specific and time-saving [30,40]. This lowers the
stakes of implementation as lack of time or motivation
often seem to prevent wide adoption among physi-
cians [41]. The application of the new coefficient
SDMMASS m a yb et o oc o m p l e xf o rs o m ep u r p o s e s .
Typically, either questionnaires (from only one per-
spective) or observer instruments are used to assess
SDM. We rather see SDMMASS as a gold standard
w h i c hm a ys e r v ea sar e f e r e n c em e a s u r et ob eu s e dt o
validate and calibrate other instruments which may be
less precise and comprehensive but providing higher
practicability. So far, no other existing measure com-
bines patient’s, physician’sa n do b s e r v e r ’sv i e wi no n e
single measure being deduced from a coherent mea-
surement system which is based on thorough theoreti-
cal considerations [18]. Therefore we assume this trial
to inform the debate on SDM interventions as well as
on SDM measurement.
Nevertheless the trial has some limitations. First, the
condensed structure of the intervention which has been
chosen for economic reasons in this trial may in turn
lead to smaller intervention effects. Second, participation
of the study centers in general and of the physicians in
particular is voluntary. This may produce a selection
bias towards highly motivated physicians producing
non-representative consultations for analysis. Although
randomization to study arms prevents major threats of
validity, the results might overestimate the effect of the
intervention when transferred to the average physician.
Third, the sample is neither homogeneous regarding
medical discipline nor a representative cross section of
physicians. Further studies have to figure out generalisa-
bility of the results as well as characteristics specific to
certain indications. Fourth, allocation concealment may
be undermined if physicians from different groups
exchange information about their schedules. However,
the control group receives the complete training with
only a short delay (1-2 weeks) which makes it unlikely
that serious frustration influences performance in this
group.
Trial Status
Recruitment of participants started in June 2011 and is
expected to end in June 2012.
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